Likewise, based on the observation that TRAIL sensitivity in cancer cells was associated with high glycosylation profiles, the seminal work of Avi Ashenazi’s laboratory, provided the first molecular demonstration that DR5-mediated TRAIL-induced cell death could be regulated by the O-glycosylation [148]. This evidence concerns the gene TNFRSF10B and cancer.